GlassScriptPhysician profile
Sophia Thang
NPI 1386206407
$11,755.42
in general payments reported to CMS, 2019-2025
45 companies · $3,210 in 2025
The $3,210 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.16 · 2020: $255 · 2021: $947 · 2022: $2,461 · 2023: $3,291 · 2024: $1,554 · 2025: $3,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,033 · Travel and Lodging: $1,879 · Education: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,033.39 |
| Travel and Lodging | $1,879.01 |
| Education | $143.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,816.48 | 2022-2025 | Impella |
| Penumbra, INC. | $1,543.82 | 2022-2025 | Penumbra System |
| Boston Scientific Corporation | $1,389.11 | 2020-2025 | Lux-Dx Insertable Cardiac Monitor, Rotablator Rotational Atherectomy System Console Kit, General - Vascular Access |
| Astrazeneca Pharmaceuticals LP | $527.68 | 2020-2024 | Wainua, Farxiga |
| Philips North America LLC | $517.95 | 2022-2025 | Igt Devices Undivided, (Ak6) Vest Therapy |
| Medtronic, INC. | $512.08 | 2024-2025 | Turbohawk, Symplicity G3, Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $446.59 | 2020-2024 | Xarelto |
| Cardiva Medical, INC. | $351.67 | 2025 | Cardiva Vascade 5f Vcs, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| United Therapeutics Corporation | $330.85 | 2023-2025 | Tyvaso, Tyvaso |
| Grifols USA, LLC | $316.36 | 2022-2025 | Prolastin-C Liquid |
| Chiesi USA, INC. | $303.17 | 2021-2025 | Kengreal |
| Cvrx, INC. | $296.14 | 2023-2024 | Barostim Neo System |
| Pfizer INC. | $282.36 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $264.11 | 2022-2024 | Jardiance |
| Abbott Laboratories | $258.94 | 2025 | Ensite, Perclose Prostyle, Cardiomems |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $159.28 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $149.32 | 2025 | Camzyos, Eliquis |
| Bard Peripheral Vascular, INC. | $146.81 | 2025 | Rotarexs 6 F X 135 Cm, Dorado, Lutonix Drug Coated Balloon |
| Novo Nordisk INC | $137.76 | 2021-2024 | Wegovy |
| Merck Sharp & Dohme LLC | $137.74 | 2021-2025 | Verquvo, Belsomra |
| Esperion Therapeutics, INC. | $133.53 | 2024 | Nexletol, Nexlizet |
| Amgen INC. | $91.43 | 2021-2025 | Repatha, Repatha |
| Surmodics, INC. | $80.73 | 2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Sublime Microcatheter, 018, 200cm, Straight |
| Cordis US Corp. | $45.27 | 2025 | Mynx Control Venous |
| Kestra Medical Technology Services, INC. | $40.94 | 2025 | Assure Wcd |
| Abbvie INC. | $35.51 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $35.31 | 2024 | |
| Mylan Specialty L.P. | $34.30 | 2023 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $32.94 | 2025 | Dupixent |
| Daxor Corporation | $28.92 | 2023 | Bva-100 |
| Alnylam Pharmaceuticals INC. | $28.39 | 2025 | Amvuttra |
| Allergan, INC. | $26.38 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $25.00 | 2025 | |
| Vapotherm INC | $24.52 | 2019 | |
| Cook Medical LLC | $22.53 | 2025 | Cook Celect |
| Resmed Corp | $22.08 | 2024 | |
| Angiodynamics, INC. | $22.05 | 2023 | Auryon Laser System 100-120 Vac |
| Gilead Sciences, INC. | $21.21 | 2021 | |
| Astellas Pharma US INC | $19.40 | 2021 | |
| Harmony Biosciences LLC | $18.61 | 2023 | Wakix |
| Kowa Pharmaceuticals America, INC. | $17.43 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.94 | 2024 | Lifevest |
| Edwards Lifesciences Corporation | $15.42 | 2020 | |
| Idorsia Pharmaceuticals US INC | $14.98 | 2023 | Quviviq |
| Eisai INC. | $14.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sophia Thang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.